
Revolution Medicines, Inc.
USD190.51
-2.11 (-1.10%)
CEO
Mark A. Goldsmith
IPO Date
2020-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$189.53
Prev. Close
$192.62
Day Low
$189.02
Day High
$192.79
52W Low
$34.00
52W High
$192.80
Market Cap
$40.50B
Volume
0.34M
| 1 Jun 2026 |
| Oppenheimer |
| Outperform |
| Outperform |
| maintain |
| 7 May 2026 | Guggenheim | Buy | Buy | maintain |
| 7 May 2026 | Needham | Buy | Buy | maintain |
| 7 May 2026 | RBC Capital | Outperform | Outperform | maintain |
| 7 May 2026 | Piper Sandler | Overweight | Overweight | maintain |
| 7 May 2026 | Wedbush | Outperform | Outperform | maintain |
| 22 Apr 2026 | HC Wainwright & Co. | Buy | Buy | maintain |